Table II.
Correlation between miR-200a expression level and clinical features of glioma patients.
Cancer tissue | Serum | ||||||
---|---|---|---|---|---|---|---|
Clinical feature | n | Relative expression level of miR-200a | P-value | t-value | Relative expression level of miR-200a | P-value | t-value |
Age (years) | |||||||
≤50 | 29 | 0.41±0.08 | >0.05 | 0.1218 | 0.35±0.04 | >0.05 | 0.9015 |
>50 | 16 | 0.45±0.03 | 0.36±0.07 | ||||
Sex | |||||||
Male | 19 | 0.40±0.11 | >0.05 | 0.9145 | 0.32±0.06 | >0.05 | 0.3419 |
Female | 26 | 0.47±0.06 | 0.36±0.02 | ||||
Pathological grade | |||||||
III | 12 | 0.53±0.05 | <0.05 | 0.0126 | 0.39±0.05 | <0.05 | 0.0063 |
IV | 33 | 0.33±0.04 | 0.28±0.03 | ||||
Tumor diameter (cm) | |||||||
≤5 | 30 | 0.51±0.07 | <0.05 | 0.0083 | 0.34±0.04 | <0.05 | 0.0168 |
>5 | 15 | 0.42±0.09 | 0.26±0.04 | ||||
Tumor location | |||||||
Frontal lobe | 16 | 0.41±0.06 | >0.05 | 1.2462 | 0.31±0.06 | >0.05 | 0.8761 |
Temporal lobe | 20 | 0.39±0.04 | 0.29±0.03 | ||||
Occipital lobe | 9 | 0.43±0.04 | 0.33±0.01 |